565 related articles for article (PubMed ID: 24586656)
1. Prevalence of premorbid metabolic syndrome in Spanish adult workers using IDF and ATPIII diagnostic criteria: relationship with cardiovascular risk factors.
Tauler P; Bennasar-Veny M; Morales-Asencio JM; Lopez-Gonzalez AA; Vicente-Herrero T; De Pedro-Gomez J; Royo V; Pericas-Beltran J; Aguilo A
PLoS One; 2014; 9(2):e89281. PubMed ID: 24586656
[TBL] [Abstract][Full Text] [Related]
2. The Prevalence of Metabolic Syndrome and Its Components among Type 2 Diabetes Mellitus Patients at a Tertiary Hospital, Northwest Ethiopia.
Biadgo B; Melak T; Ambachew S; Baynes HW; Limenih MA; Jaleta KN; Tachebele B; Melku M; Abebe M
Ethiop J Health Sci; 2018 Sep; 28(5):645-654. PubMed ID: 30607080
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of metabolic syndrome and Framingham cardiovascular risk scores in adult inpatients taking antipsychotics - a retrospective medical records review.
Wysokiński A; Kowman M; Kłoszewska I
Psychiatr Danub; 2012 Sep; 24(3):314-22. PubMed ID: 23013638
[TBL] [Abstract][Full Text] [Related]
4. Discordance of metabolic syndrome and abdominal obesity prevalence according to different criteria in Andean highlanders: A community-based study.
Herrera-Enriquez K; Narvaez-Guerra O
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S359-S364. PubMed ID: 28284909
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India.
Yadav D; Mahajan S; Subramanian SK; Bisen PS; Chung CH; Prasad GB
Glob J Health Sci; 2013 Sep; 5(6):142-55. PubMed ID: 24171882
[TBL] [Abstract][Full Text] [Related]
6. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.
Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TM; Colman PG; Manning P; Fulcher G; Keech AC;
Cardiovasc Diabetol; 2011 Nov; 10():102. PubMed ID: 22104275
[TBL] [Abstract][Full Text] [Related]
7. A Tale of Three Gorges in the Yangtze River: Comparing the Prevalence of Metabolic Syndrome According to ATPIII, WHO, and IDF Criteria and the Association with Vascular Health in Modernizing China.
Woo KS; Hu YJ; Chook P; Wei AN; Chan R; Yin YH; Celermajer DS
Metab Syndr Relat Disord; 2019 Apr; 17(3):137-142. PubMed ID: 30835162
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional study.
Maksimovic MZ; Vlajinac HD; Radak DJ; Marinkovic JM; Jorga JB
BMC Cardiovasc Disord; 2012 Jan; 12():2. PubMed ID: 22292476
[TBL] [Abstract][Full Text] [Related]
9. An examination of the prevalence of IDF- and ATPIII-defined metabolic syndrome in an Irish screening population.
Waterhouse DF; McLaughlin AM; Sheehan F; O'Shea D
Ir J Med Sci; 2009 Jun; 178(2):161-6. PubMed ID: 19129978
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of metabolic syndrome in Gwalior region of Central India: A comparative study using NCEP ATP III, IDF and Harmonized criteria.
Subramani SK; Mahajan S; Chauhan P; Yadav D; Mishra M; Pakkirisamy U; Prasad GBKS
Diabetes Metab Syndr; 2019; 13(1):816-821. PubMed ID: 30641814
[TBL] [Abstract][Full Text] [Related]
11. Gender and age-related differences in patients with the metabolic syndrome in a highly endogamous population.
Bener A; Mohammad AG; Ismail AN; Zirie M; Abdullatef WK; Al-Hamaq AO
Bosn J Basic Med Sci; 2010 Aug; 10(3):210-7. PubMed ID: 20846127
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of metabolic syndrome with International Diabetes Federation Criteria and ATP III Program in patients 65 years of age or older.
De Luis DA; Lopez Mongil R; Gonzalez Sagrado M; Lopez Trigo JA; Mora PF; Castrodeza Sanz J;
J Nutr Health Aging; 2010 May; 14(5):400-4. PubMed ID: 20424809
[TBL] [Abstract][Full Text] [Related]
13. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography.
Saely CH; Koch L; Schmid F; Marte T; Aczel S; Langer P; Hoefle G; Drexel H
Diabetes Care; 2006 Apr; 29(4):901-7. PubMed ID: 16567835
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of the International Diabetes Federation definition of metabolic syndrome in Chinese patients older than 30 years and diagnosed with type 2 diabetes mellitus.
Lu B; Yang Y; Song X; Dong X; Zhang Z; Zhou L; Li Y; Zhao N; Zhu X; Hu R
Metabolism; 2006 Aug; 55(8):1088-96. PubMed ID: 16839846
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of metabolic syndrome in Murcia Region, a southern European Mediterranean area with low cardiovascular risk and high obesity.
Gavrila D; Salmerón D; Egea-Caparrós JM; Huerta JM; Pérez-Martínez A; Navarro C; Tormo MJ
BMC Public Health; 2011 Jul; 11():562. PubMed ID: 21752307
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A Comparative Assessment Based on Criteria Established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program.
Yayıcı Köken Ö; Kara C; Can Yılmaz G; Aydın HM
J Clin Res Pediatr Endocrinol; 2020 Mar; 12(1):55-62. PubMed ID: 31434460
[TBL] [Abstract][Full Text] [Related]
17. Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study.
Via-Sosa MA; Toro C; Travé P; March MA
BMC Public Health; 2014 May; 14():487. PubMed ID: 24885099
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
[TBL] [Abstract][Full Text] [Related]
19. Performance of two metabolic syndrome definitions in the estimation of cardiovascular disease among hypertensive patients.
Hirota AH; Rodrigues CJ; Borges RL; Ribeiro AB; Zanella MT; Batista MC
J Clin Hypertens (Greenwich); 2010 Aug; 12(8):588-96. PubMed ID: 20695935
[TBL] [Abstract][Full Text] [Related]
20. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
